EHC Stock Recent News
EHC LATEST HEADLINES
NEW YORK , Aug. 29, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Encompass Health Corporation (NYSE: EHC) resulting from allegations that Encompass Health may have issued materially misleading business information to the investing public. So what: If you purchased Encompass Health securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Encompass Health Corporation (NYSE: EHC) resulting from allegations that Encompass Health may have issued materially misleading business information to the investing public.
NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Encompass Health Corporation (NYSE: EHC) resulting from allegations that Encompass Health may have issued materially misleading business information to the investing public. So What: If you purchased Encompass Health securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation ("Encompass" or the "Company") (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
On July 15, 2025, Encompass stock fell 10.4% to $107.28 after a NYT report revealed poor safety, high readmissions, and fatal errors at its hospitals.
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Encompass Health Corporation (NYSE: EHC) resulting from allegations that Encompass Health may have issued materially misleading business information to the investing public. So What: If you purchased Encompass Health securities you may be entitled to compensation without payment of any out of pocket fees or costs through a cont.
Here is how Encompass Health (EHC) and Idexx Laboratories (IDXX) have performed compared to their sector so far this year.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.